REQUEST A DEMO
Total
USD $0.00
Search more companies

Kck Pharmaceutical Industries Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Kck Pharmaceutical Industries Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Kck Pharmaceutical Industries Sdn. Bhd. is a company based in Malaysia, with its head office in Bayan Lepas. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on July 29, 1992. In its most recent financial highlights, the company reported a net sales revenue increase of 82.94% in 2022. Over the same period, its total assets grew by 15.14%. The net profit margin of Kck Pharmaceutical Industries Sdn. Bhd. increased by 1.71% in 2022.

Headquarters
Plot 61, Bayan Lepas Industrial Park, Phase4
Bayan Lepas; Penang; Postal Code: 11900

Contact Details: Purchase the Kck Pharmaceutical Industries Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Kck Pharmaceutical Industries Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Kck Pharmaceutical Industries Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Kck Pharmaceutical Industries Sdn. Bhd. report to view the information.
Incorporation Date:
July 29, 1992
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
71.87%
Purchase this report to view the information.
28.13%
Company Performance
Financial values in the chart are available after Kck Pharmaceutical Industries Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
82.94%
Total operating revenue
82.94%
Operating profit (EBIT)
67.56%
EBITDA
61.98%
Net Profit (Loss) for the Period
60.28%
Total assets
15.14%
Total equity
-6.08%
Operating Profit Margin (ROS)
1.63%
Net Profit Margin
1.71%
Return on Equity (ROE)
8.84%
Debt to Equity Ratio
6.36%
Quick Ratio
-0.01%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?